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cell activation by nonself peptide–major histocompat-
ibility complex (MHC) antigenic complexes can be
blocked by particular sequence variants in a process
termed T cell receptor antagonism. The inhibition mechanism
is not understood, although such variants are encountered
in viral infections and may aid immune evasion. Here, we
study the effect of antagonist peptides on immunological
synapse formation by T cells. This cellular communication
process features early integrin engagement and T cell motility
arrest, referred to as the “stop signal.” We ﬁnd that synapses
T 
 
formed on membranes presenting antagonist–agonist com-
plexes  display reduced MHC density, which leads to re-
duced T cell proliferation that is not overcome by the co-
stimulatory ligands CD48 and B7-1. Most T cells fail to
arrest and crawl slowly with a dense ICAM-1 crescent at the
leading edge. Similar aberrant patterns of LFA-1/ICAM-1
engagement in live T–B couples correlate with reduced
calcium ﬂux and IL-2 secretion. Hence, antagonist peptides
selectively disable MHC clustering and the stop signal,
whereas LFA-1 valency up-regulation occurs normally.
 
Introduction
 
At the heart of the adaptive immune response lies the ability
of T cells to recognize processed foreign antigens. T cell acti-
vation is initiated and restricted by the cell surface bind-
ing of peptide–major histocompatibility complex (pMHC)
ligands by the T cell receptor (TCR; Davis et al., 1998).
Framed by the engagement of adhesion molecules such as
CD2/CD48 and LFA-1/ICAM-1, the TCR is phosphory-
lated by Src-family kinases such as Lck and Fyn, which allows
the docking of downstream effectors such as ZAP-70, LAT,
SLP-76, and PLC-
 
 
 
, and subsequent signaling cascades that
stimulate the T cell to divide, differentiate, and express pro-
teins that ultimately guide the cells of the immune response
(Dustin and Chan, 2000). Costimulatory molecules such as
CD28/CD80 and CD40L/CD40 interact rapidly after ini-
tial TCR triggering. This process is sensitive to the kinetic
parameters that govern TCR–pMHC complex formation
(Matsui et al., 1994; Lyons et al., 1996; Kersh et al., 1998),
but other factors, such as pMHC stability (Holler and
Kranz, 2003) or large changes in heat capacity, (Krogsgaard
et al., 2003) can also play a role.
Altered peptide ligands (APLs) are variants of wild-type
TCR-activating peptides that produce a range of effects
from differential cytokine production to null peptides with
no activity (Sloan-Lancaster and Allen, 1996). Antagonist
peptides are a rare subset of APL that block T cell activation
to otherwise stimulatory concentrations of agonist ligand
(De Magistris et al., 1992; Sloan-Lancaster et al., 1994). In
general, antagonist ligands have lower affinities and faster
off-rates for a given TCR than agonists (Lyons et al., 1996;
Wu et al., 2002), with some exceptions (Sykulev et al.,
1998). Structural studies have indicated that in at least one
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case, the poor affinity of an antagonist ligand can be ex-
plained by a packing defect in its association with TCR
when complexed to MHC (Baker et al., 2000). The filling
of this space increases the affinity and is sufficient to revert
the peptide into an agonist. Antagonist pMHC complexes
usually need to be in excess of activating (agonist) pMHC
complexes on the antigen-presenting cell (APC) surface to
block T cell activation, although there are exceptions, nota-
bly in the class I MHC/CD8
 
 
 
 T cell system (Purbhoo et
al., 1998; Sykulev et al., 1998). Antagonist peptides clearly
have physiological relevance, as some pathogens may use an-
tagonist peptide mutants of dominant MHC epitopes to
hinder the T cell response during the course of infection.
Such antagonist variant epitopes are thought to play a role in
HIV and HBV viral modulation of T cell immunity (Berto-
letti et al., 1994; Klenerman et al., 1994; Purbhoo et al.,
1998).
Recently, it has been found that T cell activation occurs in
the context of a highly organized membrane junction be-
tween the T cell and the APC termed the immunological
synapse (Monks et al., 1998; Grakoui et al., 1999). The hall-
marks of a mature synapse are binding and transport of
pMHC complexes into the central supramolecular activa-
tion complex (cSMAC), surrounded by a more extensive in-
tegrin-rich region, the peripheral supramolecular activation
complex (pSMAC; Bromley et al., 2001a). Integrins link cy-
toskeletal rearrangement and cell adhesion to engagement of
extracellular matrix or cell surface ligands. As adhesion pre-
cedes mature synapse formation, integrins serve an indis-
pensable function in the formation of the immunological
synapse (Dustin and Chan, 2000). LFA-1 (
 
 
 
L
 
 
 
2) is argu-
ably the most important integrin for leukocyte function,
regulating T cell activation and contact formation via inter-
actions with its cell surface ligands ICAM-1, -2, or -3. TCR
signaling causes an increase in the affinity/avidity/valency of
LFA-1 for its ligands, through an “inside-out” signaling pro-
cess involving differential cytoskeletal association and ligand
induced conformational changes (Kucik et al., 1996; Takagi
et al., 2002; Kim et al., 2003). Signaling through LFA-1 also
aids synapse formation by synergizing with CD28 in trigger-
ing the active transport of TCR/CD3 to the cSMAC in acti-
vated (Wulfing and Davis, 1998; Wulfing et al., 2002), but
not naive, T cells (Bromley and Dustin, 2002). Lastly, inte-
grin engagement (“outside-in”) along with signals down-
stream of the TCR complex serve to modulate the cessation
of T cell migration upon activation, collectively termed the
“stop signal” (Dustin et al., 1997; Dustin, 2002). Correlat-
ing with a mature synapse pattern, the stop signal arises from
Ca
 
2
 
 
 
-dependent arrest of cell motility and down-modula-
tion of myosin motor function as well as T cell cytoskeletal
remodeling that stabilizes the cell–cell interface, allowing a
long-lived contact and continuous TCR-driven signaling
(Dustin, 2003; Huppa et al., 2003; Jacobelli et al., 2004).
Hence, as corroborated by in vivo intravital imaging in
mouse lymph nodes, antigen recognition on activated den-
dritic cells by naive T cells leads to stable contact formation
concurrent with cytokine production (Mempel et al., 2004).
Here, we characterize the effects of TCR antagonism on
the formation of the immunological synapse, using both a
supported lipid bilayer system and live B cells to present
pMHC complexes. Simultaneous presentation of antagonist
and agonist peptide-loaded MHC molecules in the presence
of integrin ligands reduces T cell adhesion to membranes at
limiting antigen concentration. Although a similar fraction
of adherent T cells are able to cluster MHC, the density of
MHC in the cSMAC is significantly reduced in the antago-
nized contacts compared with the null peptide control. This
decrease correlates with a block in T cell proliferation that is
not rescued by incorporation of the costimulatory ligands
B7-1 and CD48 into the bilayer. For the majority of T cells
unable to stop and form a stable contact, integrin engage-
ment as monitored by ICAM-1 accumulation occurs in a
unique crescent-shaped pattern at the leading edge. Surpris-
ingly, the density of integrin ligand in these moving contacts
is equivalent to that of pSMAC-localized integrins in a ma-
ture, stable synapse, suggesting that up-regulation of LFA-1
binding to ICAM-1 does occur but is not sufficient for T
cell arrest in the bilayer system. We extend these findings to
live three-dimensional imaging of the T–B cell interface and
demonstrate that copresentation of antagonist and agonist
pMHCs invokes similar ICAM-1 accumulation patterns, al-
though these T cells maintain contact with the B cell sur-
face. Nonetheless, antagonist pMHCs compromise down-
stream effector functions such as elevated intracellular Ca
 
2
 
 
 
and IL-2 secretion. Hence, TCR antagonists hinder synapse
formation by attenuating the stop signal but not integrin
activation, manifested as a dense sickle-like pattern of inte-
grin ligand engagement. In addition, antagonists decrease
pMHC transport to the cSMAC in the contacts that can
overcome this effect, which may be the result of direct com-
petition for TCR binding while lacking sufficient interac-
tion for complete signaling.
 
Results
 
TCR antagonism and MHC cluster density
 
To model the interaction of a CD4
 
 
 
 effector T cell encoun-
tering an APC with a mixture of activating and antagonistic
peptides on its surface, we used a planar bilayer system pre-
senting a fixed density of glycosyl-phosphatidyl inositol
(GPI) linked class II MHC I-E
 
k
 
 (100 per square micron,
20% peptide loading), containing a mixture of wild-type
moth cytochrome 
 
c
 
 (MCC; 88–103) and either of the single
amino acid peptide mutants K99R (antagonist) or K99A
(null). These APLs bind MHC as well as the wild-type
MCC peptide and were used to represent their functional
class throughout this study. The same peptide concentra-
tions were used at all times (10 
 
 
 
M, optimal for MHC load-
ing) to generate the same pMHC densities in order to avoid
variation in pMHC complex formation. At a 1:10 dilution
of MCC into 10 
 
 
 
M of total peptide, the density of agonist/
MHC achieved on the bilayer (10 molecules per square mi-
cron) was well within the threshold required to arrest T cell
migration and to trigger synapse formation, as similar frac-
tions of cells adhered tightly to the bilayer for both APLs
(Fig. 1 a). Likewise, a comparable subset of cells accumu-
lated MHC in the synapse for both the 99R and 99A pep-
tide mixtures (Fig. 1 a). At a 1:100 dilution of MCC, the ag-
onist/MHC density (1 per square micron) was near the
threshold of detection for this system (Grakoui et al., 1999; 
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Bromley et al., 2001b). Even though the fraction of cells
that formed an MHC cluster was once again similar, less
than half as many T cells could adhere and form a tight con-
tact with the bilayer containing excess antagonist peptide
compared with control null peptide (Fig. 1 a, 17% vs. 38%).
From the subset of these cells that accumulated MHC, we
quantified the density of MHC in the central cluster.
Throughout the entire range of dilutions of agonist into ex-
cess antagonist peptide 99R, there was a significant decrease
(to below 50 per square micron) in the density of MHC
clustered in the synapse as compared with excess null pep-
tide 99A (Fig. 1 b).
The equilibrium MHC cluster density has been shown
to directly correlate with the extent of T cell activation
(Grakoui et al., 1999). As predicted, the lower cluster den-
sity of MHC in the single cell contacts affected by antago-
nist pMHCs caused a significant decrease in T cell prolifer-
ation (Fig. 1 c). Addition of the extracellular domains of
the costimulatory ligands B7-1 and CD48 to the bilayer
as purified GPI-linked molecules augmented proliferation
but did not overcome the antagonism effect (Fig. 1 d),
which is consistent with experiments using T cells and
APC, which express these ligands at comparable densities
(Sloan-Lancaster and Allen, 1996). CD2-CD48 engage-
ment did increase T cell activation at these ligand densities,
in accord with a recent report (Zaru et al., 2002). We also
noticed a synergistic effect of CD48 and B7-1 in increasing
T cell proliferation, with a concomitant change in their ac-
cumulation patterns when both were present (unpublished
data). These primed “effector” CD4
 
 
 
 T cells were fairly
insensitive to B7-1 in the absence of CD48, in marked
contrast to naive T cell activation with planar membranes
(Bromley et al., 2001b). In summary, antagonist peptides
in excess over agonists can cause a decrease in MHC den-
Figure 1. Adhesion and MHC accumulation at limiting agonist concentrations. (a) T cell adhesion to bilayers presenting agonist and APL. 
Primed 5C.C7 T cells were incubated with membranes containing ICAM and MHC in a parallel-plate flow chamber. The MHC was loaded 
with MCC agonist and excess APLs, either a null peptide (99A) or an antagonist (99R). After 30 min, the ratio of input cells that formed tight 
interfaces (average synapse area  50  m
2) as judged by IRM (adhesion, gray bars) and those that could cluster MHC (black bars) were 
scored. (b) Antagonists reduce MHC density in the cSMAC. From the subset of T cells that accumulated MHC, the cluster density was quantified 
(Grakoui et al., 1999). Both pairwise comparisons are P   0.01 by t test. (c) Antagonists reduce T cell proliferation. A bilayer with no protein 
(PC) was included as a negative control. Error bars represent average of two independent experiments normalized to the same MHC density. 
The difference between 99A and 99R is significant with P   0.05 by t test. (d) CD2 and CD28 ligands do not overcome TCR antagonism. 
Density of molecules on bilayer are as follows: MHC, 100 per square micron (10% peptide loaded); CD48, 175 per square micron; B7-1, 175 
per square micron. (e) Antagonized T cells are unable to reform contacts upon disruption. T cells in contact with the bilayer for  1 h are then 
induced to detach over 2–5 min with a pulse of cold buffer. The ratio of cells able to reform contacts within 30 min is scored. (n   200 cells, 
P   0.001). Note that the ratio of T cells that initially adhere is similar for the two peptide mixtures (a, adhesion at 1:10 dilution). Results are 
representative of three experiments. 
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sity in the immunological synapse, together with a signifi-
cant decrease in T cell activation.
 
Readhesion blocked by antagonism
 
TCR antagonism is thought to create an anergic state that
renders the T cell unable to respond to antigen for up to sev-
eral days following exposure to antagonist peptides (Sloan-
Lancaster and Allen, 1996). To investigate anergy in our sys-
tem, we took advantage of our previous observation that
formation of a tight interface between bilayer and T cell ob-
servable by interference reflection microscopy (IRM) is highly
dependent on productive TCR signaling (Grakoui et al.,
1999). After allowing T cells to adhere to bilayers with 1:10
dilutions of MCC into the APL in a flow chamber, we dis-
rupted the contacts by pulsing with cold buffer, which
causes gradual detachment of the cell from the bilayer mem-
brane. The temperature was then returned to 37
 
 
 
C and the
T cells were scored using IRM for the ability to reform tight
contacts. When we compared T cell contact reinitiation on
bilayers where either antagonist (99R) peptide or the null
(99A) variant were combined with agonist, we saw a signifi-
cant decrease in the percentage of T cells that were able to
reestablish tight contact (Fig. 1 e, 6.4% vs. 20.2%, respec-
tively). It is important to note that initial adhesion rates for
the two conditions at this peptide dilution were very similar
(Fig. 1 a, adhesion at 1:10 was 60% vs. 59%). This refrac-
tory state lasted for at least half an hour. Hence, T cells were
inhibited from activation, at least with respect to adherence
and synapse formation, by prior exposure to a mixture of ag-
onist and antagonist ligands.
We have recently shown that the “null” peptide MCC99A,
although having no biological activity on its own, can never-
theless participate in agonist-driven MHC clustering and
augment T cell activation at low MHC densities (Wulfing et
al., 2002). The bilayer experiments described here are at
higher densities where this synergistic effect has not been ob-
served. Nevertheless, to rule out that the deleterious effects
of 99R compared with 99A on T cell activation is not simply
a result of the loss of this property of 99A, we have also
made comparisons with 99E, another MCC variant that
forms a pMHC complex that does not contribute in any
detectable manner to synapse formation or activation (Wulf-
ing et al., 2002). We found that 99R still displayed antago-
nism when compared with 99E (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200404059/DC1), which
is consistent with previous results (Rabinowitz et al., 1996).
 
Unique ICAM-1 engagement pattern 
during TCR antagonism
 
Studying the patterns of GPI-linked ICAM-1 accumulation
in the presence of antagonist peptides, among the majority
of T cells that were unable to form a bona fide synapse with
MHC accumulation, we noticed a prominent crescent- or
sickle-like accumulation of ICAM -1 (Fig. 2, a and b). This
phenotype predominated at higher agonist pMHC densities
while maintaining excess antagonist, and was clearly differ-
ent than the patterns of ICAM-1 on bilayers without agonist
or with antagonist pMHC alone (Grakoui et al., 1999), but
was similar to ICAM-1 engagement in mobile contacts
formed by ionomycin-anergized Th1 cells (Heissmeyer et
al., 2004). Cells with this aberrant integrin accumulation
did not stop and reorient toward the bilayer, but slowly
crawled (3 
 
 
 
m/min 
 
 
 
 0.7 
 
 
 
m) in the direction of the polar-
ized ICAM-1 sickle. Their migration paths resembled long
alternating arcs (r 
 
  
 
15 
 
 
 
m) directed away from the site of
initial contact (Fig. 2 c). LFA-1 on the T cell could appar-
ently engage and aggregate its ligand ICAM-1, despite the
fact that the stop signal was blocked by TCR antagonism.
Similar patterns were also observed with another antagonist
variant of MCC, T102G (unpublished data). The addition
of PMA, a phorbol ester that activates PKC, was unable to
Figure 2. Antagonist peptide complexes in the presence of agonist can cause a distinct ICAM-1 accumulation pattern. Primed 5C.C7 
T cells were exposed to bilayers containing MHC loaded with MCC agonist and antagonist peptides. The brightfield (dic) (a) and ICAM-1 
fluorescence (b) panels are of a T cell representative of this “sickle-like” phenotype on a bilayer with 1:2 ratio of agonist/antagonist; more T 
cells formed this pattern at higher ratios of antagonist versus agonist (provided agonist density was within limits of T cell sensitivity). Higher 
agonist density, with the excess antagonist present, also led to more ICAM-1 sickles and the associated crawling behavior (see Video 1). This 
ICAM-1 shape was rarely seen with agonist diluted into other (null) APLs (e.g., at this ratio, 84% of contacting cells on an antagonist-agonist 
bilayer showed the sickle phenotype, whereas with the same ratio of null peptide only 12% showed this shape, consistent with the 13% 
crescent-shaped accumulations reported by Somersalo et al. [2004] with human CD8  T cells in the absence of TCR agonists on the bilayer). 
T cells migrated rapidly in arc-shaped paths toward the ICAM-1 accumulation and away from the point of contact, as depicted in panel c. 
Each yellow trace, beginning with contact at top left, outlines the ICAM-1 accumulation of the same T cell at 4-min intervals. Bar, 10  m. 
ICAM, 225 per square micron; MHC, 350 per square micron. Results are representative of at least five experiments. 
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provide the stop signal or alter the pattern of ICAM-1 accu-
mulation (unpublished data). To further investigate this
event at more optimal concentrations of agonist for T cell
activation and LFA-1 up-regulation, we formed a two-
component pMHC system featuring high-density mobile
pMHC coupling through His-tagged MHC I-E
 
k
 
 and Ni-
NTA lipid derivatives, as well as lipids (GPI) covalently cou-
pled to MHC as used here and in previous experiments
(Grakoui et al., 1999). Using this new method, we could
achieve mobile MHC densities of several thousand mole-
cules per square micron, which could activate T cells and
cluster into synapses (unpublished data).
Using excess antagonist (99R)-loaded His-MHC on the
same membrane as GPI-linked MHC with the agonist MCC
peptide covalently attached to the MHC 
 
 
 
 chain (referred to
as 
 
 
 
32; Wulfing et al., 2002), we characterized T cell behav-
ior and ICAM-1 accumulation. On these bilayers, a majority
of T cells adhered and formed the sickle-shaped ICAM-1 ac-
cumulations that we had previously observed, migrating away
from the point of initial membrane contact (Fig. 3 a and
Figure 3. Sustained interaction with antagonist-MHC affects ICAM accumulation density and geometry. (a) 5C.C7 T cell blasts were allowed 
to interact with bilayers expressing ICAM-1, MCC-tethered GPI-MHC ( 32) and excess 99R-loaded His-MHC complexes. ICAM-1 (red) is 
intensity normalized for each sequence to best demonstrate accumulation pattern. The inset in pseudocolor compares the final cluster 
intensity using the same scale for all three conditions. Most T cells showed the sickle-like ICAM-1 pattern and crawling pattern. (b) With no 
 32 (antagonist-MHC alone), T cells exhibit decreased ICAM-1 clustering (left, inset; ICAM-1 density is 1/3 that in panel a) and more random 
crawling patterns, which is consistent with previous findings (Grakoui et al., 1999). Arrowheads denote the same T cell at the four time 
points. (c) After 1 h of contact, cells on the mixed TCR ligand bilayer in panel a reverted to more randomly distributed ICAM-1 patterns and 
lower ICAM-1 density consistent with antagonist-mediated anergy. However, migration was still slowed and the cells retained close contact 
with the bilayer. (d) ICAM-1 density in contacts (a, 99R MCC; b, 99R alone; c, a after 1 h), a direct indicator of LFA-1 valency. T cells from 
panel a were able to cluster ICAM-1 to levels as high as those forming mature synapses on agonist alone (Grakoui et al., 1999), and several-
fold higher than cells on antagonist alone (b). After 1 h of contact (c), the ICAM-1 density decreased, consistent with the pattern change in 
ICAM engagement, indicating that the T cells could no longer respond to the agonist. Bars, 10  m. 99R-MHC, 750 per square micron; ICAM, 
190 per square micron; MCC-MHC (a and c), 75 per square micron; MCC-MHC (b), 0. Density quantification is representative of two 
independent experiments. 
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Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200404059/DC1). Stable MHC clustering was not ob-
served in any of these mobile contacts (unpublished data). In
contrast, T cells on a bilayer with 99R-MHC (without 
 
 
 
32)
exhibited much less efficient adhesion, with sparse ICAM-1
accumulation at the contact area (Fig. 3 b and Video 2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200404059/
DC1). Hence, antagonist peptide itself does not elicit the
sickle-shaped ICAM-1 accumulation pattern seen with a
combination of agonist and antagonist ligands. Cell motility
also occurred in a more random pattern, in accord with previ-
ous data of ICAM-1 engagement on bilayers presenting any
nonactivating pMHC (Grakoui et al., 1999). Consistent with
the results shown in Fig. 1 e, when we imaged the bilayer in
Fig. 3 a after 1 h of contact, we found that the T cells did
indeed appear anergized, as defined by the loss of the
sickle-shaped ICAM-1 accumulation that had formed
upon initial contact (Fig. 3 c and Video 3, available at http://
www.jcb.org/cgi/content/full/jcb.200404059/DC1). The
ICAM-1 pattern after 1 h generally resembled that of T cells
on antagonist alone, despite having more ICAM-1 at the in-
terface (Fig. 3 c, right). In addition, the T cells did not break
contact with the bilayer or lapse into the random crawling
patterns seen without agonist peptide present.
Figure 4. ICAM-1 patterns and antagonism in live B cell–T cell couples. 2B4 T cell blasts were incubated with CH27 B cells expressing an 
ICAM-GFP fusion protein (Wulfing et al., 1998). (a) When the B cells were loaded with 10  M MCC, consistent with previous results (Wulfing 
et al., 1998), the T cells showed tight contact formation, a sustained calcium flux, and an early concentrated central ICAM-1 accumulation. 
The first two panels show brightfield (dic) and intracellular Ca
2 , and the last two ICAM-1 fluorescence, with a midfield plane followed by a 
three-dimensional reconstruction panel, the first image depicting the T–B cell interface and the second another area of the B cell membrane 
as control. The top and bottom series show time before and after contact and the same pseudocolor scale for calcium used for all four panels 
is shown in the topmost panel (numbers are fold over average baseline),  t   60s. (b) At a 1:100 dilution of agonist into antagonist, most 
( 60%) T cell–B cell interactions resulted in an ICAM-1 pattern similar to that seen in the bilayer system (Figs. 2 and 3). The ICAM-1 interface 
panels are reconstructed from a series of images at 1- m z-planes through the cell. In panel a, the first image shows the T cell interface as 
seen from the B cell side, and the adjacent image the membrane area directly opposite the T cell contact. In panel b, the T–B cell interface of 
the nonfluxing cell (top right) is instead shown as the control. (c) TCR antagonism correlates with decreased calcium flux: for example, the 
cell in panel a has about threefold higher calcium upon contact than the one in panel b. B cells loaded with the indicated peptide mixtures 
(all dilutions of MCC into APL) were allowed to interact with Fura-2–loaded T cells. Greater than 500 T cells were scored for elevated 
calcium levels. P   0.01 between 99A and 99R dilutions by t test. Results are representative of two independent experiments. 
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ICAM-1 density and LFA-1 engagement
 
The initial high intensity ICAM-1 engagement was indic-
ative of efficient LFA-1 binding, likely through avidity
up-regulation and mobilization at the interface. To deter-
mine the extent of LFA-1 engagement, we quantified the
ICAM-1 molecular density in contacts formed in these ex-
periments. Surprisingly, we found that the ICAM-1 den-
sity in the sickle-like patterns initially formed on antago-
nist-agonist MHC bilayers was very high (Fig. 3 d),
comparable to the amount measured for ICAM-1 in ma-
ture synapses with agonist-MHC alone (Grakoui et al.,
1999). Conversely, on antagonist ligand alone, T cells did
not accumulate much ICAM-1 over background, which is
consistent with a requirement for TCR signaling through
PKC to shift LFA-1 to high affinity (Dustin and Springer,
1989). Over time, the ICAM-1 density decreased as the T
cells were anergized, consistent with the change in the
ICAM-1 pattern seen when the rightmost panels in Fig. 3
(a and c) are compared. Thus, ICAM-1 density in the T
cell contact, which is an accurate indicator of LFA-1 en-
gagement, was elevated to levels seen with agonist alone,
indicating that at least this aspect of TCR signaling,
namely integrin valency up-regulation, was functioning in
the presence of antagonist-MHC. Nonetheless, high-den-
sity integrin engagement alone was not sufficient to over-
come the attenuation of the stop signal by antagonist
TCR ligands.
 
Integrin engagement and TCR antagonism in live 
T–B cell interface
 
To extend these results to live, costimulation-competent
APCs, we used the B cell lymphoma CH27 expressing a
GFP-linked ICAM-1 molecule. Consistent with previous re-
sults (Wulfing et al., 1998), B cells loaded with the MCC
peptide caused T cells to form tight contacts leading to ele-
vated intracellular calcium and the early accumulation of
ICAM-1 into a small, dense cluster at the center of the syn-
apse (Fig. 4 a). At this peptide concentration, 
 
 
 
1.5% of the
MHCs on the B cell surface are occupied by the peptide as
detected with pMHC specific antibody staining (unpub-
lished data). Given the MHC density of 220 per square mi-
cron for these cells, this resulted in an average plasma mem-
brane agonist-MHC density of 3 pMHC molecules per
square micron, or 
 
 
 
2400 pMHCs per cell. When we di-
luted the agonist into 100-fold excess of antagonist peptide,
resulting in 0.03 agonist pMHC per square micron (
 
 
 
20
per cell), we saw that the T cells were still able to adhere to
the APCs, and form flat interfaces and flux calcium, albeit
intermittently. Approximately half these contacts showed
very little ICAM-1 accumulation over background and cor-
related with little or no calcium flux (Fig. 4 b, top right).
However, most of the T cells that formed productive con-
tacts with elevated calcium accumulated ICAM-1 in asym-
metric patterns very similar to the sickle-like ones seen on
planar bilayers (Fig. 4 b, bottom left), although the clusters
Figure 5. Antagonist peptides can 
block T cell effector function at limiting 
agonist densities. 5C.C7 T cell blasts 
were incubated with CH27-ICAM-GFP 
B cells with the indicated peptide concen-
trations for 56 h, after which IL-2 levels 
were quantified by ELISA and normalized 
to recombinant murine IL-2 standards. 
For the ratios shown in the two bottom 
right panels, and at 0.01  M MCC and 
lower, no IL-2 above background (assay 
sensitivity is to 1–10 U/ml range) could 
be detected. Pairwise comparisons at 
0.1, 1, and 10  M APL and 0.1  M 
MCC (top rightmost three graphs) are 
significant, with P   0.05 by t test. The 
top right graph features the same peptide 
ratio as in the microscopy experiments 
represented by Fig. 4 b. Results are repre-
sentative of two independent experiments. 
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often appeared as patches of higher intensity arrayed in an
elongated shape with positive curvature around the perime-
ter of the T cell contact rather than the contiguous regions
of more uniform intensity on bilayers. Consistent with these
observations, we found that at these agonist/antagonist ra-
tios significantly fewer T cells overall were fluxing calcium at
any given time (Fig. 4 c).
To look at functional downstream effects in these live cell
couples, we quantified IL-2 secretion levels in T cells al-
lowed to react with the same B cells loaded with very small
amounts of agonist peptide and different amounts of the
APLs 99A or 99R. This approach takes advantage of recent
results showing that peptide loading on live CH27 cells is
linear down to the range of 0.1–0.05 
 
 
 
M by a direct pep-
tide-labeling method (Irvine et al., 2002). Extrapolating
from this study and previous quantification of MCC loading
on CH27 (Wulfing et al., 2002), we estimated the agonist
pMHC density on the B cell surface as 0.03 per square mi-
cron (20 molecules per cell) at 0.1 
 
 
 
M of free MCC and
0.015 per square micron (10 per cell) at 0.05 
 
 
 
M of free
MCC. At a density of 0.003 per square micron (2 per cell) at
0.01 
 
 
 
M MCC, near the sensitivity limit of T cells (Irvine et
al., 2002), we could not detect any IL-2 secretion (unpub-
lished data). At these low but physiologically relevant levels
of antigen, the antagonist 99R reduced IL-2 secretion at
1:100 (same ratio as in Fig. 4 b), 1:10, and even 1:1 ratios to
MCC, as compared with the null peptide 99A (Fig. 5).
Thus, the aberrant ICAM-1 pattern, as evidenced by de-
creased calcium signaling and a block in downstream effec-
tor functions, also accompanied TCR antagonism in live T
cell–APC couples and corroborated our previous findings in
the supported lipid bilayer system.
 
Discussion
 
In the experiments described here, we have characterized the
effect of antagonist peptides on the formation of the immu-
nological synapse by CD4
 
 
 
 effector T cells. We find that
synapses that form in the presence of antagonists show
marked defects in MHC and ICAM-1 dynamics. Although
the precise function of a mature T cell synapse, as defined by
a central cluster of TCR/pMHC surrounded by engaged in-
tegrins, is not yet understood (Lee et al., 2002a; Zaru et al.,
2002), its formation does correlate very well with a robust T
cell response. In particular, the density of pMHC in the
cSMAC correlates directly with the stability of TCR-ligand
binding and the extent of T cell activation (Grakoui et al.,
1999). Antagonist peptides alone promote neither MHC
clustering (Monks et al., 1998; Grakoui et al., 1999) nor
Lck accumulation (Erlich et al., 2002). Here, we find that
antagonist peptides nonetheless can interfere with pMHC
clustering, reducing T cell proliferation and inducing an an-
ergic state that hinders readhesion to the antigen-presenting
membrane. T cells are unable to accumulate antagonist
pMHC and exhibit a sickle-shaped pattern of integrin ligand
(ICAM-1) engagement. The high ICAM-1 density in these
aberrant synapses is consistent with normal LFA-1 valency
up-regulation (Hibbs et al., 1991). Despite this apparent ac-
tivation of LFA-1 through inside-out signaling, the T cells
do not stop on the bilayers, which likely accounts for the
shape of the ICAM-1 accumulation at the leading edge.
Similarly, we find that live T cell–B cell couples also have a
polarized, asymmetric accumulation of ICAM-1 (Fig. 4 b)
when antagonists and agonists are present at the T–B cell in-
terface, although in this case the T cells are able to arrest,
presumably due to additional ligands on the B cell that are
not present on the bilayers. It is also possible that in vitro
models of cell–cell interaction using cell suspensions on a
flat glass surface do not allow sufficient discrimination be-
tween slow crawling versus full stop behavior. Our efforts to
address this issue through quantifying T cell migration over
the B cell surface were confounded by random motion and
B cell rotation due to convection currents and the absence of
a three-dimensional matrix for cell adhesion and support.
The full resolution of this issue awaits an appropriate high
resolution in vivo imaging model.
The stop signal that is most evident using the two-dimen-
sional system of supported lipid bilayers can be viewed as a
model for antigen recognition in vivo, which is accompanied
by T cell motility arrest in nearly every experimental ap-
proach to date. One notable exception is a recent study of
naive T cells entering peripheral lymph nodes, which show
an initial phase of rapid, “random-walk” migration even in
the presence of potent activating signals in the form of anti-
gen-loaded dendritic cells. This phase, lasting several hours,
occurs before the T cells settle down to stable, long-lived in-
teractions consistent with the stop signal and presumably in-
volving the formation of a mature synapse (Mempel et al.,
2004). The cellular mechanism(s) responsible for the initial
refractive phase of high T cell motility in the face of antigen
exposure is not known, and evidently not recapitulated in
the model systems used in this work. This behavior may be a
result of additional cues only present in intact lymph nodes,
including pro-migratory factors such as chemokines that
have been shown to overcome the stop signal under certain
conditions (Bromley et al., 2000). Alternatively, the T cells
themselves may be altered in some way due to their recent
extravasation through the high endothelial venules, perhaps
via metalloprotease-mediated proteolysis of adhesion recep-
tors, and require this initial phase to reexpress surface pro-
teins or signaling intermediates that are necessary for T cell
motility arrest.
Current models for TCR antagonism invoke a range of
phenomena from kinetic competition to conformational
changes in the TCR subunits or negative signal spreading
(Sloan-Lancaster and Allen, 1996; Dittel et al., 1999). Sev-
eral studies using dual TCR expressing T cells to study an-
tagonism (Daniels et al., 1999; Dittel et al., 1999; Stotz et
al., 1999; Wang and Grey, 2003) have reported conflicting
results. Antagonist peptides can alter tyrosine phosphoryla-
tion patterns on the CD3
 
 
 
 chain (Sloan-Lancaster et al.,
1994; Madrenas et al., 1995) although this has not been
universally observed (Liu and Vignali, 1999) and its rele-
vance to antagonism has been challenged (Pitcher et al.,
2003). Nonetheless, these partially-phosphorylated mole-
cules could inhibit T cell activation. As seen in Fig. 3 c, the
ICAM-1 sickle pattern is lost over time with continued ex-
posure to antagonist peptides. Likewise, in our readhesion 
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assay (Fig. 1 e), T cells on agonist-antagonist bilayers were
unable to reestablish a disrupted contact. These findings
suggest that continuous engagement by antagonist pMHC
creates a pool of inactive TCR that gradually disables the
ability of the T cell to respond to agonist ligand.
A subset of peptides that are unable to activate T cells
(null peptides) can nonetheless cocluster in the synapse in
the presence of agonists and augment T cell activation
within a lower range of MHC density (Wulfing et al.,
2002). Null and antagonist versions of TCR ligands both
possess weaker binding kinetics and lower half-lives of inter-
action with the TCR (Lyons et al., 1996; Wu et al., 2002).
However, these two types of APL have different effects on
TCR signaling and synapse formation when copresented
with agonist ligands. In particular, null pMHC complexes
have no measurable affinity for their cognate TCR (Lyons et
al., 1996; Wu et al., 2002), but clearly do bind as they are
recruited into the synapse in a TCR dependent manner
(Wulfing et al., 2002). Furthermore, they clearly do not act
as antagonists. We propose that this apparent discrepancy
might be best addressed by a kinetic model (Fig. 6), where
decreasing the half-life of interaction (
 
t
 
1/2
 
 
 
 
 
 ln2/k
 
off
 
) of an
agonist ligand would produce effects ranging from reducing
the activating potential of the peptide (weak agonist), to cre-
ating ligands with antagonist properties, and finally null
ligands that may be compatible with TCR-MHC binding
but do not engage long enough to signal. Mathematical
modeling of receptor engagement in the immunological syn-
apse has shown the importance of kinetic boundary condi-
tions that affect molecular patterning (Lee et al., 2002b).
Rapid, transient interactions whose kinetics fit the postu-
lated optimal range for antagonism (Fig. 6) may disrupt
the cytoskeletal-driven TCR transport to the center of the
synapse that characterizes agonist engagement (Wulfing
and Davis, 1998) hinder CD4-TCR association (Zal et al.,
2002) or prevent TCR oligomerization as suggested by the
results of Reich et al. (1997). This model also poses the test-
able prediction that for any given TCR there exists a kinetic
half-life window where any ligand falling within this range
will behave as a TCR antagonist.
Of the downstream mediators of TCR signaling, the only
pathway activated by antagonist peptide ligands alone is re-
ported to be SLP-76 recruitment, followed by Vav phos-
phorylation, and Rac-1 and JNK activation (Huang et al.,
2000b). ZAP-70 and LAT are not phosphorylated and there
is no clustering of PKC
 
 
 
 at the interface (Huang et al.,
2000a). In the former report, Vav was found to be activated
through Fyn kinase rather than Lck. Because TCR antago-
nism can occur even in the absence of the CD3
 
 
 
 chain (Liu
and Vignali, 1999) and Fyn is predicted to favor interactions
with the other ITAMs of the TCR (i.e., those on the CD3
 
 
 
,
 
 
 
, and 
 
 
 
 chains), perhaps antagonists exert their effects pri-
marily through Fyn and the single ITAM-bearing CD3
chains. Thus, it is relevant that Rac-1 phosphorylation can
lead to cytoskeletal rearrangement in the T cell (Acuto and
Cantrell, 2000). In the presence of antagonist pMHC,
asymmetric integrin engagement in the synapse could be
due to inopportune Rac-1 activation as Lck and Fyn com-
pete to differentially activate Vav and dictate cytoskeletal re-
distribution, with Lck favoring a mature synapse and Fyn
a more transient interaction coupled with T cell migra-
tion. The finding that Vav controls both TCR and integrin
clustering through different pathways (a pathway through
WASP and an unknown pathway involving Pyk2, respec-
tively) supports this view (Krawczyk et al., 2002).
Similar to our previous work (Wulfing et al., 2002), an-
other study has described the coclustering of null pMHC
with agonist using effector T cells and dendritic cells as
APCs (Chmielowski et al., 2002). In contrast, naive T cells
“expel” null peptides from the agonist pMHC core, which is
postulated to occur via an active mechanism specific to anti-
gen inexperienced cells. Antagonist peptide, but not another
null peptide, interferes with this expulsion and causes resdis-
tribution across the whole T cell contact. These observations
can now be put into context by the work presented here: the
exclusion effect in naive T cells is likely due to less efficient
null pMHC retention arising from less TCR accumulation
at the cSMAC compared with effector T cells. TCR trans-
port deficiency in noneffector T cells is well documented,
evidenced by slower or only transient pMHC clustering in
naive T cells (Lee et al., 2002a) and thymocytes (Richie et
al., 2002). In addition, a recent paper shows that human na-
ive (but not effector) CD8
 
 
 
 T cells are deficient in their
ability, independent of antigen, to cluster integrins into a
pSMAC ring pattern termed the “presynapse” (Somersalo et
al., 2004). Hence the enhanced cytoskeletal activity of effec-
Figure 6. A model for a narrow kinetic range for TCR antagonism. 
The curve represents a hypothetical distribution of pMHC complexes 
as a group of ligands for a given TCR. Moving from right to left start-
ing with rare agonist peptides that optimally stimulate T cells, as t1/2 
(half life of TCR-pMHC interaction) decreases, more peptides show 
weaker activation potential (increased f, frequency of peptide), 
eventually leading to a null phenotype where irrespective of their 
ability to participate in MHC clustering (Wulfing et al., 2002), these 
peptides by themselves do not stimulate T cells. TCR antagonist 
peptides are postulated to occupy a narrow kinetic window between 
weak agonists and null ligands, with a sufficient time of interaction 
for an aberrant or incomplete signal, whereas null peptides do not 
bind long enough to elicit any signal on their own. 
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tor T cells would be better able to retain null pMHC cor-
ralled at the cSMAC. Antagonists may hinder this effect
simply by reducing MHC cluster density, as we show here
(Fig. 1 b). The fact that antagonism leads to null pMHC
spreading out across the whole interface argues against an ac-
tive “expulsion process” in naive T cells. If that were indeed
the case, antagonists would block this putative process and a
central cluster of null pMHC would rather be observed,
as with effector T cells. Finally, we note that sickle-like
ICAM-1 patterns have also been recently observed in a study
of ionomycin-anergized Th1 cells (Heissmeyer et al., 2004).
The stop signal is similarly compromised, despite some
MHC clustering. Hence, that work and ours together sup-
port the hypothesis that an aberrant integrin engagement
pattern and an abrogated stop signal may comprise novel
hallmarks of T cell anergy. In summary, our work comple-
ments and extends these studies in quantifying the precise
molecular densities of MHC and ICAM-1 and showing how
antagonist peptide APLs perturb the density and geometry
of molecules at the T cell synapse.
The value of TCR antagonism to a pathogen could be to
blunt the immune response toward rare agonist epitopes to
defuse T cell help during an infection, especially for small
and highly mutagenic viral genomes with a limited number
of MHC epitopes for the T cell repertoire. Likewise, HIV
can generate Gag epitope variants that act as antagonists to
block T cell activation (Klenerman et al., 1994). Our results
demonstrate that antagonist peptides, in addition to their
role in inhibiting MHC accumulation in the mature syn-
apse, can also disrupt synapse formation by bypassing the
stop signal that is normally elicited by antigen engagement,
leading to an aberrant integrin pattern and slow but sus-
tained T cell motility. We also show that an increase in inte-
grin avidity alone through inside-out signaling is not suffi-
cient to initiate the T cell stop signal.
 
Materials and methods
 
Cells, peptides, and proteolipid bilayers
 
5C.C7 and 2B4 primary T cell blasts were generated by adding 10  M
MCC (88–103) peptide to lymph node suspensions from TCR transgenic
mice and used 7–12 d later (Grakoui et al., 1999). The CH27 B cell lym-
phoma expressing ICAM-1-GFP has been described previously (Wulfing et
al., 1998). All peptides are single amino acid variants of wild-type MCC
(88–103, ANERADLIAYLKQATK) at residue 99K, predicted to be the pri-
mary TCR contact, and were purified by HPLC. GPI-linked ICAM-1 and
I-E
k were affinity purified from transfected CHO cells and labeled with Cy5
(Amersham Biosciences) and Oregon green (Molecular Probes) on amine
groups as described previously (Bromley et al., 2001b).  32-I-E
k (created
by L.C. Wu, Genentech, South San Francisco, CA) features wild-type MCC
covalently tethered to the MHC   chain (Wulfing et al., 2002). GPI-linked
proteoliposomes were generated by standard techniques and molecular
density was quantified by RIA with appropriate 
125I-labeled antibodies
(YN1 for ICAM-1, 14.4.4 for I-E
k). Proteoliposomes containing Cy3-CD80
and Cy5-CD48 were contributed by S.K. Bromley (Massachusetts General
Hospital, Charlestown, MA). G35 and D4 antibodies, specific for peptide-
I-E
k, were used to measure peptide loading efficiency by RIA. His-tagged
(6  His on COOH terminus of both   and   chains) I-E
k (a gift from L. Tey-
ton, The Scripps Research Institute, La Jolla, CA) was produced in S2 insect
cells and purified first by anion exchange chromatography (Mono Q; Am-
ersham Biosciences), followed by Ni-NTA agarose (QIAGEN). His-I-E
k was
loaded with CLIP(85–99, KPSVQMRMATPLLMR) before anion exchange
to maintain dimer stability during high salt elution; it was exchanged to
MCC or its variants after purification. Proteoliposomes with 5% DOGS
(1,2-dioleoyl-SN-Glycero-3-{[N(5-amino-1-carboxypentyl) iminodiacetic
acid]succinyl}) in DOPC (1,2-di-oleoyl-SN-glycero-3-ethylphosphocho-
line; both from Avanti Polar Lipids, Inc.) were used to couple the His-MHC
to the bilayer and simultaneously present GPI-linked ICAM-1 and  32-I-
Ek. Loading and imaging was done in the presence of 10  M Ni
2 . Higher
maximal densities ( 4000 molecules/ m
2) and less dependence on free
Ni
2  were obtained with His-I-E
k than with single-His tagged HLA-A2
(1200–500 molecules/ m
2), showing that His tag valency plays a role in
coupling efficiency to Ni-NTA lipid bilayers. T cells could accumulate
Alexa488 (Molecular Probes)-labeled, wild-type MCC agonist loaded His-
I-E
k into a central cluster in the synapse, concomitant with proliferation, in-
dicating that the MHC was mobile and bound in an orientation able to
productively interact with TCR.
T cell functional assays
Proliferation of T cells on bilayers was assayed in a 96-well format. Bilay-
ers were formed from 1 l of vesicle droplets on the bottom of the well,
sandwiched by a heat treated (450 C for 8 h) 5-mm coverslip, blocked
with 0.2  m filtered BSA solution (2% BSA [Sigma-Aldrich] in 50 mM ci-
trate/phosphate, and 50 mM NaCl) and loaded with peptides overnight at
37 C. After peptide loading, the wells were washed with 10% FCS/RPMI
and each glass coverslip flipped in solution to rest with the bilayer side fac-
ing up. T cells were added for 48h at 37 C, followed by 12–16 h of
[
3H]thymidine (Amersham Biosciences) incorporation, transfer to filtermat,
and quantification by liquid scintillation (1205 Betaplate; Wallac). IL-2
was quantified from a T cell–B cell coculture assay (relevant peptides
added to 1   10
5 T and 10
4 B cells/well in 10%FCS/RPMI and incubated at
37 C for 56 h) by a standard sandwich ELISA using epitope-matched anti-
bodies (BD Biosciences) and Europium detection (Victor; Wallac).
Microscopy and image analysis
Two fluorescent videomicroscopy systems outlined in detail previously
(Dustin et al., 1997; Wulfing et al., 2002) were used to collect and process
images. The first is a custom inverted microscope (Yona Microscopes) us-
ing a 100  objective (model Neofluar; Carl Zeiss MicroImaging, Inc.),
cooled CCD camera (Photometrics) and IP Lab control software (Signal
Analytics). The second is an Axiovert S100TV (Carl Zeiss MicroImaging,
Inc. or Universal Imaging Corp.) system using a 63  Neofluar objective,
175W Xenon lamp (Sutter Instrument Co.), and an interline cooled CCD-
1330-V/HS (Princeton Instruments). Bilayers for imaging were formed in a
parallel plate flow chamber (FCS2; Bioptechs) or in 8-well chambers (Lab-
tek; Nunc) with 5-mm coverslips. GPI-protein density in contacts from flat-
field and background corrected images was quantified as reported previ-
ously (Grakoui et al., 1999). ICAM-1 accumulation patterns at the T–B cell
interface were generated by three-dimensional reconstruction of back-
ground corrected 1  m z-planes collected with a piezo PIFOC motor
(Physik Instrumente) mounted underneath the objective, using Metamorph
software (Universal Imaging Corp.). Additional image processing used
Photoshop, Illustrator (Adobe), and Graphic Converter (Lemke Software).
Activation state was monitored by a calcium sensitive dye (Fura-2; Molec-
ular Probes). To judge readhesion efficiency, ice-cold imaging buffer (defi-
cient RPMI [GIBCO BRL], 10% FCS, and 10 mM Hepes) was pulsed into
the flow chamber, leading to gradual detachment of the T cells which re-
mained in the field, enabling tracking. As the media warmed back to 37 C,
the percentage of T cells previously in contact with the bilayer that could
reform a tight contact was scored.
Online supplemental material
Fig. S1 shows that 99R displays TCR antagonism whether compared with
99A or 99E. The same experimental conditions as in Fig. 5 were used, rep-
resentative of two experiments. Videos 1–3 correspond respectively to the
experiments in Fig. 3, panels a–c. Original image capture was at 30 sec-
onds per frame (shown at 1 second per frame), and each video represents
10 min of imaging. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200404059/DC1.
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